U.S. Army scientists have launched a phase 1 clinical trial of an experimental vaccine against the Middle East respiratory syndrome coronavirus, DoD News reported Feb. 17. Cheryl Pellerin writes researchers at the
Register to enjoy unlimited access to articles, interviews, and invaluable govcon content. You'll also receive our daily briefing straight to your inbox.